Evidence map›Paper›PMID 33462674›Full record

ArticleMetabolomics : Official journal of the Metabolomic Society2021

Metabolic consequences for mice lacking Endosialin: LC-MS/MS-based metabolic phenotyping of serum from C56Bl/6J Control and CD248 knock-out mice.

Emily G Armitage, Alan Barnes, Kieran Patrick, Janak Bechar, Matthew J Harrison, Gareth G Lavery, G Ed Rainger, Christopher D Buckley, Neil J Loftus, Ian D Wilson and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Metabolomics : Official journal of the Metabolomic Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Emily G Armitage *Shimadzu Corporation, Manchester, UK.
Alan Barnes *Shimadzu Corporation, Manchester, UK.
Kieran Patrick *Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Janak BecharInstitute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Matthew J HarrisonInstitute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.
Gareth G LaveryInstitute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.
G Ed RaingerInstitute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.
Christopher D BuckleyInstitute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Neil J LoftusShimadzu Corporation, Manchester, UK.
Ian D WilsonDepartment of Metabolism, Digestion and Reproduction, Imperial College, London, UK.
Amy J NaylorInstitute of Inflammation and Ageing, University of Birmingham, Birmingham, UK. a.naylor@bham.ac.uk.ORCID http://orcid.org/0000-0001-8384-8215
University of Birmingham · GBShimadzu (United Kingdom) · GBImperial College London · GBUniversity of Oxford · GB

Funding

British Heart Foundation FS/14/42/30956British Heart Foundation RG/12/7/29693Versus Arthritis 19791Versus Arthritis 21743
6 · The paper itself

Abstract

introductionThe Endosialin/CD248/TEM1 protein is expressed in adipose tissue and its expression increases with obesity. Recently, genetic deletion of CD248 has been shown to protect mice against atherosclerosis on a high fat diet.

objectivesWe investigated the effect of high fat diet feeding on visceral fat pads and circulating lipid profiles in CD248 knockout mice compared to controls.

methodsFrom 10 weeks old, CD248

resultsWe demonstrate a specific reduction in the size of the perirenal fat pad in CD248

conclusionsOverall these results show a clear and protective metabolic consequence of CD248 deletion in mice, implicating CD248 in lipid metabolism or trafficking and opening new avenues for further investigation using anti-CD248 targeting agents.

Indexed as

Chromatography, LiquidTandem Mass SpectrometryAdipose TissueAnimalsAntigens, CDAntigens, NeoplasmCarnitineCholesterolChromatography, High Pressure LiquidDiet, High-FatFemaleIntra-Abdominal FatLiverMaleMiceMice, KnockoutAntigens, CDAntigens, NeoplasmCarnitineCD248 protein, mouseCholesterolNeoplasm ProteinsPhosphatidylcholinestumor endothelial marker 1, mouseCD248EndosialinHigh fat dietHRAM UHPLC–MS/MS

Identifiers

PMID33462674
PMCPMC7813710
OpenAlexW3119063469

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.